🔗 Share this article

The prestigious award in Physiology or Medicine was granted for revolutionary findings that illuminate how the body's defense network targets dangerous pathogens while sparing the healthy tissues.

A trio of esteemed scientists—Japan's Prof. Sakaguchi and US experts Dr. Brunkow and Dr. Ramsdell—received this honor.

Their research identified specialized "security guards" within the defense system that eliminate rogue immune cells that could attacking the organism.

The findings are now enabling new therapies for immune disorders and cancer.

The winners will share a prize fund valued at 11 million SEK.

Decisive Discoveries

"The research has been decisive for understanding how the body's defenses functions and why we do not all suffer from serious self-attack conditions," stated the chair of the Nobel Committee.

This team's research explain a core mystery: How does the defense system defend us from numerous infections while leaving our healthy cells intact?

Our immune system employs white blood cells that search for indicators of infection, including pathogens and bacteria it has not met before.

These cells utilize sensors—known as recognition units—that are produced by chance in a vast number of combinations.

That provides the immune system the ability to combat a wide array of threats, but the unpredictability of the mechanism inevitably creates immune cells that can attack the host.

Protectors of the Body

Researchers previously knew that some of these harmful defense cells were eliminated in the thymus—the site where immune cells mature.

This year's Nobel Prize recognizes the discovery of T-reg cells—known as the body's "security guards"—which travel through the system to neutralize other defenders that assault the body's own tissues.

We know that this mechanism fails in self-attack conditions such as type-1 diabetes, MS, and RA.

The Nobel panel stated, "The findings have established a new field of investigation and accelerated the development of innovative therapies, for instance for tumors and autoimmune diseases."

In cancer, regulatory T-cells block the system from attacking the growth, so research are focused on lowering their numbers.

For autoimmune diseases, experiments are exploring boosting regulatory T-cells so the body is not under attack. A comparable approach could also be effective in reducing the risks of organ transplant rejection.

Innovative Experiments

Prof Shimon Sakaguchi, from Osaka University, conducted experiments on mice that had their immune gland removed, causing autoimmune disease.

The researcher demonstrated that injecting defense cells from other mice could prevent the illness—implying there was a mechanism for blocking defenders from harming the body.

Dr. Brunkow, from the Institute for Systems Biology in a US city, and Fred Ramsdell, now at a biotech firm in San Francisco, were investigating an inherited immune disorder in mice and humans that led to the discovery of a gene vital for the way T-regs operate.

"The pioneering work has revealed how the body's defenses is controlled by T-reg cells, stopping it from accidentally attacking the healthy cells," commented a leading physiology specialist.

"This work is a remarkable example of how fundamental biological research can have far-reaching consequences for public health."